SCHEMBL6924491

SCHEMBL6924491

NC(=O)c1c(N)nc2ccccc2c1C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
DHODH Q02127 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
EPHX1 P07099 1/20 0.41
CHRNA7 P36544 1/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
HPGD P15428 2/20 0.40
NUDT1 P36639 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 1/20 0.39
ATR Q13535 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
PDE5A O76074 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924495 0.80 ACHE (0.49) ATMMAPTMAPK1RECQLNPSR1
SCHEMBL28266633 0.76 TDP1 (0.56) ATMDHODHTDP1L3MBTL1EPHX1
SCHEMBL5824150 0.76 ALDH1A1 (0.49) ATMTDP1L3MBTL1ALDH1A1CYP1A2
SCHEMBL17042189 0.74 MEN1 (0.39) ATMMAPTMAPK1RECQLNPSR1
SCHEMBL29372456 0.74 MEN1 (0.39) ATMMAPTMAPK1RECQLNPSR1
SCHEMBL18824869 0.73 DHODH (0.38) ATMDHODHPOLBATRGAA
SCHEMBL5824154 0.73 ALDH1A1 (0.49) ATMTDP1L3MBTL1ALDH1A1CYP1A2
SCHEMBL28584218 0.71 KDM4E (0.40) ATMMAPTMAPK1RECQLNPSR1
SCHEMBL11546106 0.71 MAPT (0.54) MAPTMAPK1NPSR1DHODHTDP1
Formamide SCHEMBL21715187 0.70 MEN1 (0.36) MAPTMAPK1RECQLNPSR1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed